Home/Filings/4/0001894562-25-000024
4//SEC Filing

Marrazzo Jeffrey D 4

Accession 0001894562-25-000024

CIK 0001894562other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 7:45 PM ET

Size

436.6 KB

Accession

0001894562-25-000024

Insider Transaction Report

Form 4
Period: 2025-05-19
Transactions
  • Award

    Stock Option (right to buy)

    2025-05-19+800,000800,000 total
    Exercise: $1.33Common Stock (800,000 underlying)
Footnotes (1)
  • [F1]500,000 of the shares underlying this option shall vest and become exercisable in twenty-four (24) equal monthly installments over a two-year period commencing from May 19, 2025; 300,000 of the shares underlying this option shall vest and become exercisable in three equal installments based on the Issuer's satisfaction of certain performance criteria tied to stock price, in each case subject to the Reporting Person's continued service on each such vesting date.

Issuer

Prime Medicine, Inc.

CIK 0001894562

Entity typeother

Related Parties

1
  • filerCIK 0001631262

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 7:45 PM ET
Size
436.6 KB